Protagonist Therapeutics, Inc. ($PTGX)
Filing Information
| Accession Number | 0001104659-26-007127 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
43,151
Total Value
$1,985,705.42
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jan 23, 2026 | Sale | 13,151 | $82.42 | $1,083,905.42 | 84,115 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 26, 2026 | Exercise/Conversion | 5,000 | $8.04 | $40,200.00 | 89,115 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 26, 2026 | Sale | 5,000 | $82.28 | $411,400.00 | 84,115 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 27, 2026 | Exercise/Conversion | 5,000 | $8.04 | $40,200.00 | 89,115 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jan 27, 2026 | Sale | 5,000 | $82.00 | $410,000.00 | 84,115 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Jan 26, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 70,971 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Jan 27, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 65,971 | Direct | โ | View Details |